GGrantIndex
Sort

261,768 grants matching gene therapy

Immunotherapeutics for Treatment of Flavivirus Infection

$1,254,949
Erol Fikrig · Yale University · U01 · FY2008 · AI

Influence of Task Complexity and Sensory Feedback on Cortical Control of Grasp Force

$1,254,924
Jennifer L. Collinger · University Of Pittsburgh At Pittsburgh · U01 · FY2023 · NS

Clinical Refinement of islet transplantation

$1,254,896
Nicole Ann Turgeon · Emory University · U01 · FY2010 · AI

DNA Replication, Cancer and Chemotherapy

$1,254,803
Melvin Depamphilis · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2021 · HD

Tulane National Primate Research Center

$1,254,800
Benjamin Paul Sachs · Tulane University Of Louisiana · P51 · FY2009 · RR

PEDIATRIC AIDS CLINICAL TRIALS GROUP

$1,254,565
St. Jude Children'S Research Hospital · U01 · FY2001 · AI

Immunoregulation /Immune Recognition In Filarial/Nonfilarial Parasitic Infection

$1,254,541
Thomas Nutman · National Institute Of Allergy And Infectious Diseases · ZIA · FY2017 · AI

Novel Approaches for Tau PROTAC Drug Discovery

$1,254,536
Karteek Kadimisetty · Lifesensors, Inc. · R44 · FY2023 · AG

GENE THERAPY RESOURCE PROGRAM (GTRP): PHARMACOLOGY AND TOXICOLOGY CORE LABORATORY

$1,254,413
Terrance Flotte · Lovelace Biomedical Research Institute · N01 · FY2022 · HL

PPG: SARS-CoV-host cell interactions and vaccine development

$1,254,329
Stanley Perlman · University Of Iowa · P01 · FY2020 · AI

PPG: SARS-CoV-host cell interactions and vaccine development

$1,254,329
Stanley Perlman · University Of Iowa · P01 · FY2019 · AI

PPG: SARS-CoV-host cell interactions and vaccine development

$1,254,329
Stanley Perlman · University Of Iowa · P01 · FY2021 · AI

Therapeutic targets and novel anticancer agents for endocrine cancers

$1,254,239
Naris Nilubol · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA

Molecular Genetics Of Heritable Human Disorders

$1,254,196
Janice Chou · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2014 · HD

FFNP-PET as a predictive biomarker of response to endocrine therapy approaches in advanced breast cancer

$1,254,028
Kooresh Isaac Shoghi · Washington University · R01 · FY2025 · CA

Radiation-induced molecular targets

$1,254,004
Norman Coleman · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA

Impact of Stretching on Tumor growth and Metastasis

$1,254,000
Helene Langevin · National Institute Of Dental & Craniofacial Research · ZIA · FY2022 · DE

Receptor-directed Therapy

$1,253,922
John Janik · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA

HIV Persistence During Suppressive Antiretroviral Therapy

$1,253,792
Frank Maldarelli · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA

Chromatin Remodeling and Gene Activation

$1,253,698
David J Clark · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2021 · HD

Mechanistic investigation of therapies for Down Syndrome Regression Disorder

$1,253,643
Joaquin M. Espinosa · University Of Colorado Denver · R33 · FY2024 · HD

Center for the Study of Inflammatory Bowel Disease at Massachusetts General Hospital

$1,253,598
Ramnik J Xavier · Massachusetts General Hospital · P30 · FY2022 · DK

Center for the Study of Inflammatory Bowel Disease at Massachusetts General Hospital

$1,253,598
Ramnik J Xavier · Massachusetts General Hospital · P30 · FY2024 · DK

Center for the Study of Inflammatory Bowel Disease at Massachusetts General Hospital

$1,253,598
Ramnik J Xavier · Massachusetts General Hospital · P30 · FY2025 · DK

Center for the Study of Inflammatory Bowel Disease at Massachusetts General Hospital

$1,253,598
Ramnik J Xavier · Massachusetts General Hospital · P30 · FY2023 · DK